The IPOList

Blogs

Home

/

FABCLEAN

Fabtech Technologies Cleanrooms

Fabtech Technologies Cleanrooms

FABCLEAN

📅

Bidding Dates

3 Jan 2025 - 7 Jan 2025

💰

Price Range

₹80 - ₹85

🔢

Minimum Investment

₹1,36,000

📊

Issue Size

28Cr

💰

Latest GMP

--

IPO Timeline

1

Issue open date

3 Jan 2025

2

Issue close date

7 Jan 2025

3

UPI mandate deadline

7 Jan 2025

4

Allotment finalization

8 Jan 2025

5

Refund initiation

9 Jan 2025

6

Share credit

9 Jan 2025

7

Listing date

10 Jan 2025

8

Mandate end date

22 Jan 2025

9

Lock-in end date for anchor investors (50%)

7 Feb 2025

10

Lock-in end date for anchor investors (remaining)

8 Apr 2025

About the Company

Fabtech specializes in manufacturing and providing design-to-validation solutions for cleanrooms in the pharmaceuticals, healthcare, and biotech sectors. They offer custom modular panels, HVAC systems, and more. With certifications, strategic investments, and key clients like Unichem Laboratories and Aurobindo Pharma, Fabtech is expanding its capabilities, including a recent acquisition in HVAC. The company, part of the Fabtech Group, has seen steady revenue and profit growth, with a strong focus on operational efficiency.

Strengths

  1. Advanced manufacturing and expertise in cleanroom panels and HVAC.
  2. Strong, long-term customer relationships.
  3. Backing from a larger group company.
  4. Experienced and professional management team.
  5. Broad domain expertise with effective project integration.
  6. Expanding market opportunities and new industry segments.

Risks

  1. Sector issues may impact the business.
  2. Reliance on few suppliers may disrupt operations.
  3. Promoter guarantees for debt may need replacements.
  4. Loan covenants could affect the business.
  5. Manufacturing shutdown may harm operations.
Made with ❤️ by Harsh Goel
Disclaimer: The content provided on theipolist.in is for educational and informational purposes only. We are not SEBI-registered advisors and are not involved in any grey market trades. Please consult with a registered financial advisor before making any investment decisions.